PDF(Pubmed)
Abstract：
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, created a rapidly unfolding health crisis, especially in the initial phases of the pandemic. In the early stages of the pandemic, various strategies were proposed for COVID-19 prophylaxis and treatment with very little scientific evidence available. Among these proposed treatments were ivermectin and chlorine dioxide, which were both used widely in Peru for both disease prevention and treatment without considering their problematic side effects. For instance, ivermectin was part of an approved therapeutic scheme based on in vitro data, although its efficacy in humans was not demonstrated. In addition, chlorine dioxide was never shown to be effective but causes threatening side effects. In this article, we discuss current information regarding chlorine dioxide and ivermectin in the context of the COVID-19 pandemic, with a focus on experiences in Peru.
摘要：
严重急性呼吸道综合症冠状病毒2（SARS-CoV-2）的传播，导致COVID-19的病毒造成了迅速发展的健康危机，特别是在大流行的初始阶段。在大流行的早期阶段，针对COVID-19的预防和治疗提出了各种策略,但几乎没有科学证据.这些建议的治疗方法包括伊维菌素和二氧化氯，在秘鲁广泛用于疾病预防和治疗，而不考虑其有问题的副作用。例如,伊维菌素是基于体外数据批准的治疗方案的一部分，尽管它在人类中的功效没有得到证明。此外,二氧化氯从未被证明是有效的，但会引起威胁性的副作用。在这篇文章中,我们在COVID-19大流行的背景下讨论有关二氧化氯和伊维菌素的最新信息，重点介绍秘鲁的经验。
